In the reading of this month's PCa Commentary, Ed Weber, MD, discusses clinical research on Decipher, a genomic risk-stratifier that estimates prognosis on the basis of the unique molecular characteristics of a man’s prostate cancer, can offer guidance in treatment decisions.
Read the full text here: [ Ссылка ]
Ещё видео!